Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells

Atherosclerosis. 2014 Oct;236(2):430-7. doi: 10.1016/j.atherosclerosis.2014.07.025. Epub 2014 Aug 15.

Abstract

Objective: Endothelial cell (EC) interacts with adjacent EC through gap junction, and abnormal expression or function of Cxs is associated with cardiovascular diseases. In patients with endothelial dysfunction, the up-regulation of tissue factor (TF) expression promotes the pathogenic activation of blood coagulation, however the relationship between gap junctions and TF expression in ECs remains uncharacterized. ECs express the gap junction (GJ) proteins connexin32 (Cx32), Cx37, Cx40 and Cx43. We investigated the role of endothelial gap junctions, particularly Cx32, in modulating TF expression during vascular inflammation.

Methods and results: Human umbilical vein endothelial cells (HUVECs) were stimulated with tumor necrosis factor-α (TNF-α) and TF activity was assessed in the presence of GJ blockers and an inhibitory anti-Cx32 monoclonal antibody. Treatment with GJ blockers and anti-Cx32 monoclonal antibody enhanced the TNF-α-induced TF activity and mRNA expression in HUVECs. TNF-α-activated effector HUVECs or mouse MS-1 cells were co-cultured with non-stimulated acceptor HUVECs and TF expression in acceptor HUVECs was detected. Effector EC induced TF expression in adjacent acceptor HUVECs through direct cell-cell interaction. Cell-cell interaction induced TF expression was reduced by anti-intercellular adhesion molecule-1 (ICAM1) monoclonal antibody. Soluble ICAM1-Fc fusion protein promotes TF expression. GJ blockers and anti-Cx32 monoclonal antibody enhanced TF expression induced by cell-cell interaction and ICAM1-Fc treatment.

Conclusion: Blockade of endothelial Cx32 increased TF expression induced by TNF-α stimulation and cell-cell interaction which was at least partly dependent upon ICAM1. These results suggest that direct Cx32-mediated interaction modulates TF expression in ECs during vascular inflammation.

Keywords: Cell–cell interaction; Connexin; Endothelial cell; Gap junction; Inflammation; Tissue factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Blood Coagulation
  • Carbenoxolone / pharmacology
  • Cell Communication
  • Cells, Cultured
  • Coculture Techniques
  • Connexins / antagonists & inhibitors
  • Connexins / deficiency
  • Connexins / physiology*
  • Endothelial Cells / metabolism*
  • Gap Junction beta-1 Protein
  • Gap Junctions / drug effects
  • Gap Junctions / physiology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Immunoconjugates / pharmacology
  • Immunoglobulin Fc Fragments
  • Intercellular Adhesion Molecule-1 / pharmacology
  • Intercellular Adhesion Molecule-1 / physiology
  • Male
  • Mice
  • Mice, Knockout
  • Oleic Acids / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Thromboplastin / biosynthesis*
  • Thromboplastin / genetics
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Vasculitis / metabolism*

Substances

  • Antibodies, Monoclonal
  • Connexins
  • Immunoconjugates
  • Immunoglobulin Fc Fragments
  • Oleic Acids
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • oleylamide
  • Thromboplastin
  • Carbenoxolone